Mitochondria‐Targeted Triphenylphosphonium Conjugated C‐3 Modified Betulin: Synthesis, Antitumor Properties and Mechanism of Action
Authors:
Open Access
- 8 December 2021
- journal article
- research article
- Published by Wiley in ChemMedChem
- Vol. 17 (4) , e202100659
Abstract
A series of mitochondria‐targeted triphenylphosphonium conjugated C‐3 modified betulin were synthesized and evaluated against tumor cells. As a result, a new derivative 13 i, the conjugate of 3‐O‐(3′‐acetylphenylacetate)‐betulin with triphenylphosphonium, was identified as the one with the best anti‐tumor effect. Conjugate 13 i significantly inhibited HCT116 cells with IC50 at 0.66 μM. While betulin, C‐3 modified betulin, and the triphenylphosphonium moiety showed no inhibition of HCT116 cell proliferation at 20 μM. More importantly, 13 i exhibited a more cytotoxic effect against the tumor cell HCT116 than normal cell NCM460. Mode of action studies demonstrated that 13 i induced the G2/M phase cell cycle arrest and apoptosis in HCT116 cells through the mitochondrial pathway. Structure‐activity relationship analysis revealed that integration of triphenylphosphonium moiety into the C‐28 of betulin can greatly improve cytotoxicity. Appropriate modification on C‐3 of the conjugate would improve the selectivity.Keywords
Funding Information
- National Natural Science Foundation of China (22177020)
This publication has 25 references indexed in Scilit:
- Betulinic Acid: Recent Advances in Chemical Modifications, Effective Delivery, and Molecular Mechanisms of a Promising Anticancer TherapyChemical Biology & Drug Design, 2015
- Calcium and mitochondria in the regulation of cell deathBiochemical and Biophysical Research Communications, 2015
- A novel derivative of betulinic acid, SYK023, suppresses lung cancer growth and malignancyOncotarget, 2015
- Apoptosis of human breast cancer cells induced by microencapsulated betulinic acid from sour jujube fruits through the mitochondria transduction pathwayFood Chemistry, 2013
- Preliminary Study of the Anticancer Applications of Mesoporous Materials Functionalized with the Natural Product Betulinic AcidChemMedChem, 2012
- New betulinic acid derivatives as potent proteasome inhibitorsBioorganic & Medicinal Chemistry Letters, 2011
- Targeting mitochondrial apoptosis by betulinic acid in human cancersDrug Discovery Today, 2009
- Chemotherapeutic Approaches for Targeting Cell Death PathwaysThe Oncologist, 2006
- Betulinic Acid and Its Derivatives: A Review on their Biological PropertiesCurrent Medicinal Chemistry, 2005
- Betulinic Acid and Dihydrobetulinic Acid Derivatives as Potent Anti-HIV AgentsJournal of Medicinal Chemistry, 1996